|
WO2019168685A1
|
|
Improvement of endothelial cell function
|
|
WO2019032437A1
|
|
Liposomal taxanes for treatment of sclc
|
|
EP3522984A1
|
|
Regenerative cell therapy for musculoskeletal disorders
|
|
WO2016054592A1
|
|
Use of regenerative cells in mitigating burn progression and improving skin graft incorporation and healing
|
|
WO2016007434A1
|
|
Centrifuge chamber
|
|
US2016177250A1
|
|
Tissue transfer system
|
|
WO2015120388A1
|
|
Regenerative cell therapy for central nervous system (cns) disorders and ptsd
|
|
WO2015042182A1
|
|
Methods of using adipose tissue-derived cells in the modulation of pain and/or fibrosis
|
|
AU2013216683A1
|
|
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
|
|
JP2012051923A
|
|
Method of using adipose tissue-derived cell in treatment of cardiovascular condition
|
|
KR20120020143A
|
|
Systems, methods and compositions for optimizing tissue and cell enriched grafts
|
|
EP2421959A1
|
|
Use adipose tissue-derived regenerative cells in the modulation of inflammation in the pancreas and in the kidney
|
|
WO2010021993A1
|
|
Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
|
|
WO2009076548A1
|
|
Methods of inhibiting tumor development using adipose-derived regenerative cells
|
|
WO2009055610A1
|
|
Syringe system for controlled delivery or removal of material
|
|
WO2008060466A2
|
|
Individualized dosage determination for local administration of therapeutic particles
|
|
US2010015104A1
|
|
Generation of adipose tissue and adipocytes
|
|
WO2007061530A1
|
|
Cell delivery catheters with distal tip high fidelity sensors
|
|
WO2007139551A1
|
|
Systems and methods for manipulation of regenerative cells from adipose tissue
|
|
WO2006112941A2
|
|
Resorbable hollow devices for implantation and delivery of therapeutic agents
|
